Indicators

Every hospital needs a local protocol for management of acute hypersensitivity reactions after CM administration, accessible in all rooms where CM are administered.

1. Hospital-wide protocols for management of acute hypersensitivity reactions after CM administration, accessible in all rooms where CM are administered
Operationalization	Is there an overall hospital-wide protocol or process-agreement for management of acute hypersensitivity reactions after CM administration? And is this protocol accessible in all rooms where CM is administered?
Numerator	Not applicable
Denominator	Not applicable
Type of indicator	Input
In- and exclusion criteria	Inclusion A hospital-wide protocol for management of acute hypersensitivity reactions after CM administration. This protocol is accessible in all rooms where CM is administered.
Quality domain	Safety and effectivity
Measuring frequency	Once a year
Report year	2020
Frequency of report	Once a year

Medication for treatment of acute reactions after CM administration should be available in every room where CM is administered.

2. Hospital-wide protocols about prevention of PC-AKI
Operationalization	Is there medication for treatment of acute reactions after CM administration available in every room where CM is administered?
Numerator	Not applicable
Denominator	Not applicable
Type of indicator	Input
In- and exclusion criteria	Inclusion Medication for treatment of acute reactions after CM administration available in every room where CM is administered. As a minimum the following medication should be available: adrenaline, salbutamol, H1-antihistamine (clemastine) IV, corticosteroid IV.
Quality domain	Safety and effectivity
Measuring frequency	Once a year
Report year	2020
Frequency of report	Once a year